241
Last Update Posted: 2017-01-12
Recruiting has ended
All Genders accepted | 22 Years-45 Years |
58 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Flupenthixol Decanoate in Methamphetamine Smoking - 1
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
Eligibility
Relevant conditions:
Substance-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov